Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

The FOCU.SE trial : a nationwide Swedish drug repurposing protocol and research framework

Mark

Abel, Edvard ; Östling, Päivi ; Hult, Ebba Hallersjö ; Kulbacka, Katarzyna ; Babacic, Haris ; Baan, Annika ; Carneiro, Ana ^LU

; De Petris, Luigi ; Fagman, Henrik and Friesland, Signe , et al. (2026) In Acta Oncologica 65. p.268-272

Please use this url to cite or link to this publication: https://lup.lub.lu.se/record/d1b39c11-83a1-4d96-b812-a4558ae8d104

author

Abel, Edvard ; Östling, Päivi ; Hult, Ebba Hallersjö ; Kulbacka, Katarzyna ; Babacic, Haris ; Baan, Annika ; Carneiro, Ana ^LU

; De Petris, Luigi ; Fagman, Henrik and Friesland, Signe , et al. (More)

Abel, Edvard ; Östling, Päivi ; Hult, Ebba Hallersjö ; Kulbacka, Katarzyna ; Babacic, Haris ; Baan, Annika ; Carneiro, Ana ^LU

; De Petris, Luigi ; Fagman, Henrik ; Friesland, Signe ; Frisell, Oskar ; Hellström, Mats ; Lindahl, Gabriel ; Carlsson, Katarina Steen ^LU

; Amborero, David ; Valachis, Antonios ; Öhlund, Daniel ; Lehtiö, Janne ; Rosenquist, Richard ; Edsjö, Anders ^LU

; Botling, Johan ; Bäckvall, Helena ; Fred, Rikard ; Garvin, Stina ; Hallqvist, Andreas ; Heidenblad, Markus ^LU

; Catela-Ivkovic, Tina ^LU ; von Sydow, Anita Koskela ; Köhn, Linda ; Lagerhorn, Rozina Caridha ; Löfgren, Maja ; Melin, Malin ; Isaksson-Mettävainio, Martin ; Moens, Lotte N.J. ; Ny, Lars ; Nord, Helena ; Olauson, Hannes ; Qvick, Alvida ; Rapisarda, Stefano and Tham, Emma (Less)

author collaboration

FOCU.SE trial group including:

organization

publishing date

2026

type

Contribution to journal

publication status

published

subject

Cancer and Oncology

keywords

biomarker profiling, cancer genomics, drug repurposing, infrastructure, multimodal analysis, platform trial, Precision medicine, PRIMEROSE consortium, proteomics, Sweden, targeted therapy

in

Acta Oncologica

volume

65

pages

5 pages

publisher

Taylor & Francis

external identifiers

scopus:105035679275
pmid:41972845

ISSN

DOI

10.2340/ao.v65.45355

language

LU publication?

yes

id

d1b39c11-83a1-4d96-b812-a4558ae8d104

date added to LUP

2026-06-24 14:58:56

date last changed

2026-06-25 03:00:04

@article{d1b39c11-83a1-4d96-b812-a4558ae8d104,
  author       = {{Abel, Edvard and Östling, Päivi and Hult, Ebba Hallersjö and Kulbacka, Katarzyna and Babacic, Haris and Baan, Annika and Carneiro, Ana and De Petris, Luigi and Fagman, Henrik and Friesland, Signe and Frisell, Oskar and Hellström, Mats and Lindahl, Gabriel and Carlsson, Katarina Steen and Amborero, David and Valachis, Antonios and Öhlund, Daniel and Lehtiö, Janne and Rosenquist, Richard and Edsjö, Anders and Botling, Johan and Bäckvall, Helena and Fred, Rikard and Garvin, Stina and Hallqvist, Andreas and Heidenblad, Markus and Catela-Ivkovic, Tina and von Sydow, Anita Koskela and Köhn, Linda and Lagerhorn, Rozina Caridha and Löfgren, Maja and Melin, Malin and Isaksson-Mettävainio, Martin and Moens, Lotte N.J. and Ny, Lars and Nord, Helena and Olauson, Hannes and Qvick, Alvida and Rapisarda, Stefano and Tham, Emma}},
  issn         = {{0284-186X}},
  keywords     = {{biomarker profiling; cancer genomics; drug repurposing; infrastructure; multimodal analysis; platform trial; Precision medicine; PRIMEROSE consortium; proteomics; Sweden; targeted therapy}},
  language     = {{eng}},
  pages        = {{268--272}},
  publisher    = {{Taylor & Francis}},
  series       = {{Acta Oncologica}},
  title        = {{The FOCU.SE trial : a nationwide Swedish drug repurposing protocol and research framework}},
  url          = {{http://dx.doi.org/10.2340/ao.v65.45355}},
  doi          = {{10.2340/ao.v65.45355}},
  volume       = {{65}},
  year         = {{2026}},
}